SunOpta Announces Third Quarter Fiscal 2023 Financial Results
- Revenue from continuing operations increased 5.9% to $152.5 million, showing positive growth.
- Adjusted EBITDA from continuing operations increased 8.1% to $19.1 million, indicating improved operational efficiency.
- The divestiture of frozen fruit operations will optimize the product portfolio for growth and profitability, strengthening the balance sheet.
- The company maintains its Q4 outlook for continuing operations, showing stability and confidence in future performance.
- The 2024 outlook indicates expected strong revenue growth of 8-13% and adjusted EBITDA growth of 14-21%, demonstrating a positive future trajectory.
- None.
Revenue from continuing operations increased
Loss from continuing operations of
Adjusted EBITDA from continuing operations increased
Maintains Q4 outlook for continuing operations and provides 2024 outlook
All amounts are expressed in
Third Quarter 2023 highlights:
-
Revenues of
$152.5 million 5.9% compared to$144.0 million 5.5% volume growth. -
Gross profit margin was
13.3% on a reported basis. Excluding start-up costs, gross margin was16.4% , down 140 basis points from17.8% mainly due to the 150 basis point increase in depreciation related to new production equipment. -
Loss from continuing operations was
$5.7 million $2.4 million -
Adjusted earnings¹ from continuing operations attributable to common shareholders was
$0.5 million $0.00 $2.4 million $0.02 -
Adjusted EBITDA¹ from continuing operations of
$19.1 million 12.5% of revenues, compared to$17.7 million 12.3% of revenues in the prior year period.
“We delivered strong volume-driven revenue growth in the third quarter from protein shakes, oat milk and snacks,” said Joe Ennen, SunOpta Chief Executive Officer. “In addition, the divestiture of our frozen fruit operations subsequent to the end of the quarter was a major strategic milestone that significantly optimizes our product portfolio for growth and profitability along with helping to reduce debt and strengthen our balance sheet, which creates opportunities for capital allocation beneficial to shareholders, including the potential adoption of a share repurchase program. Key growth initiatives continue to advance including market share gains with existing customers, new customers and total addressable market expansion. We are also in the process of replacing our existing asset-based lending arrangement, supplemented with third-party extended payable facilities and finance leases, with a term loan and revolver structure with limited finance leases, which we expect will be in place by the end of the year. With our strong foundation, leverageable platform and expanding capacity, we are confident in our direction and believe that we remain well positioned to deliver significant long-term sustainable growth and value for shareholders.”
Third Quarter 2023 Results
Revenues from continuing operations increased
Gross profit was
Operating income¹ was
Loss from continuing operations for the quarter ended September 30, 2023 was
Loss from discontinued operations was
Adjusted earnings¹ in the third quarter of 2023 was
Adjusted EBITDA¹ from continuing operations was
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
As of September 30, 2023, SunOpta had total assets of
Divestiture of Frozen Fruit
On October 12, 2023, the Company entered into an Asset Purchase Agreement with Natures Touch Mexico, S. de R.L. de C.V. and Nature’s Touch Frozen Fruits, LLC to sell certain assets and liabilities of Frozen Fruit for an aggregate purchase price of approximately
At the Closing Date, the estimated aggregate purchase price was comprised of cash consideration of
2023 Outlook2
For fiscal 2023, the Company maintains its outlook, adjusting for the divestiture of Frozen Fruit:
($ millions) |
Previous 2023 Consolidated Outlook |
2023 Frozen Fruit Outlook |
2023 Continuing Operations Outlook |
|||||
Revenue |
$ |
880 - 900 |
$ |
266 - 270 |
$ |
614 - 630 |
||
Adj. EBITDA |
$ |
87 - 91 |
$ |
12 – 14 |
$ |
75 – 77 |
||
Revenue growth |
( |
|
||||||
Adj. EBITDA growth |
|
|
||||||
2024 Outlook2
For fiscal 2024, the Company expects strong revenue growth, driven by volume and strong adjusted EBITDA growth:
($ millions) |
|
2024 Outlook |
|
|
Growth* |
||
Revenue |
$ |
670 – 700 |
|
|
|||
Adj. EBITDA |
$ |
87 - 92 |
|
|
*Expected growth based on the midpoint of the range of the 2023 outlook
Conference Call
SunOpta plans to host a conference call at 5:30 P.M. Eastern time on Wednesday, November 8, 2023, to discuss the third quarter financial results. After opening remarks, there will be a question-and-answer period. Investors interested in listening the live webcast can access a link on SunOpta's website at www.sunopta.com under the “Investor Relations” section or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number dial (888) 440-4182 or International dial-in number (646) 960-0653 using Conference ID: 8338433.
¹ See discussion of non-GAAP measures
2 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.
- Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
- Start-up costs of new facilities and equipment;
- Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
- Asset impairment charges and facility closure costs;
- Legal settlements or awards; and
- The tax effect of the above items.
About SunOpta Inc.
SunOpta (Nasdaq:STKL) (TSX:SOY) is a
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, the potential adoption of a share repurchase program, replacement of our existing asset-based lending arrangement by the end of the year, our belief that we are well positioned to deliver significant long-term sustainable growth and value for shareholders, our expectation for strong revenue growth for fiscal 2024 and our anticipated Revenue, Adjusted EBITDA , Revenue growth and Adjusted EBITDA growth for fiscal 2023 and our anticipated Revenue and Adjusted EBITDA for fiscal 2024. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “potential”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", “continue”, "becoming", "intend", "confident", "may", "project", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; our exit from, and use of proceeds from the divestiture of the assets and liabilities of, Frozen Fruit, uninterrupted operations and service levels to our customers; current customer demand for the Company’s products; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; the cost of the frozen fruit recall; labor cost reductions; and the terms of our insurance policies. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as the possibility of supply chain, logistics and other disruptions; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; potential additional costs associated with the frozen fruit recall; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.
SunOpta Inc. |
||||||||
Consolidated Statements of Operations |
||||||||
For the quarters and three quarters ended September 30, 2023 and October 1, 2022 |
||||||||
(Unaudited) |
||||||||
(All dollar amounts expressed in thousands of |
||||||||
|
||||||||
|
Quarter ended |
Three quarters ended |
||||||
|
September 30, 2023 |
October 1, 2022 |
September 30, 2023 |
October 1, 2022 |
||||
|
$ |
$ |
$ |
$ |
||||
|
|
|
|
|||||
Revenues |
152,541 |
|
144,023 |
|
448,673 |
|
431,605 |
|
|
|
|
|
|||||
Cost of goods sold |
132,273 |
|
118,891 |
|
385,697 |
|
355,691 |
|
|
|
|
|
|||||
Gross profit |
20,268 |
|
25,132 |
|
62,976 |
|
75,914 |
|
|
|
|
|
|||||
Selling, general and administrative expenses |
18,377 |
|
17,866 |
|
58,403 |
|
58,864 |
|
Intangible asset amortization |
446 |
|
446 |
|
1,338 |
|
1,338 |
|
Other expense (income), net |
- |
|
451 |
|
(20 |
) |
1,408 |
|
Foreign exchange loss (gain) |
(37 |
) |
(223 |
) |
44 |
|
(208 |
) |
|
|
|
|
|
||||
Operating income |
1,482 |
|
6,592 |
|
3,211 |
|
14,512 |
|
|
|
|
|
|
||||
Interest expense, net |
7,162 |
|
3,901 |
|
19,391 |
|
8,844 |
|
|
|
|
|
|
||||
Earnings (loss) from continuing operations before income taxes |
(5,680 |
) |
2,691 |
|
(16,180 |
) |
5,668 |
|
|
|
|
|
|
||||
Income tax expense |
- |
|
332 |
|
3,978 |
|
1,360 |
|
|
|
|
|
|
||||
Earnings (loss) from continuing operations |
(5,680 |
) |
2,359 |
|
(20,158 |
) |
4,308 |
|
Loss from discontinued operations |
(140,143 |
) |
(14,293 |
) |
(143,126 |
) |
(10,203 |
) |
Net loss |
(145,823 |
) |
(11,934 |
) |
(163,284 |
) |
(5,895 |
) |
|
|
|
|
|
||||
Dividends and accretion on preferred stock |
(426 |
) |
(764 |
) |
(1,552 |
) |
(2,279 |
) |
|
|
|
|
|
||||
Loss attributable to common shareholders |
(146,249 |
) |
(12,698 |
) |
(164,836 |
) |
(8,174 |
) |
|
|
|
|
|
||||
Basic earnings (loss) per share |
|
|
|
|
||||
Earnings (loss) from continuing operations |
(0.05 |
) |
0.01 |
|
(0.19 |
) |
0.02 |
|
Loss from discontinued operations |
(1.21 |
) |
(0.13 |
) |
(1.26 |
) |
(0.09 |
) |
Loss attributable to common shareholders(1) |
(1.26 |
) |
(0.12 |
) |
(1.45 |
) |
(0.08 |
) |
|
|
|
|
|
||||
Diluted earnings (loss) per share |
|
|
|
|
||||
Earnings (loss) from continuing operations |
(0.05 |
) |
0.01 |
|
(0.19 |
) |
0.02 |
|
Loss from discontinued operations |
(1.21 |
) |
(0.13 |
) |
(1.26 |
) |
(0.09 |
) |
Loss attributable to common shareholders(1) |
(1.26 |
) |
(0.12 |
) |
(1.45 |
) |
(0.08 |
) |
|
|
|
|
|
||||
Weighted-average common shares outstanding (000s) |
|
|
|
|
||||
Basic |
115,616 |
|
107,752 |
|
113,700 |
|
107,566 |
|
Diluted |
115,616 |
|
109,239 |
|
113,700 |
|
108,731 |
|
|
|
|
|
|
||||
(1) The sum of individual per share amounts may not add due to rounding. |
||||||||
SunOpta Inc. |
||||
Consolidated Balance Sheets |
||||
As at September 30, 2023 and December 31, 2022 |
||||
(Unaudited) |
||||
(All dollar amounts expressed in thousands of |
|
|||
|
||||
|
September 30, 2023 |
December 31, 2022 |
||
|
$ |
$ |
||
|
|
|
||
ASSETS |
|
|
||
Current assets |
|
|
||
Cash and cash equivalents |
348 |
|
679 |
|
Restricted cash |
3,196 |
|
- |
|
Accounts receivable |
60,634 |
|
59,545 |
|
Inventories |
84,332 |
|
74,439 |
|
Prepaid expenses and other current assets |
20,011 |
|
15,535 |
|
Income taxes recoverable |
3,384 |
|
4,040 |
|
Current assets held for sale |
142,070 |
|
148,119 |
|
Total current assets |
313,975 |
|
302,357 |
|
|
|
|
||
Property, plant and equipment, net |
316,500 |
|
292,306 |
|
Operating lease right-of-use assets |
84,653 |
|
78,761 |
|
Intangible assets, net |
22,307 |
|
23,646 |
|
Goodwill |
3,998 |
|
3,998 |
|
Deferred income taxes |
696 |
|
3,712 |
|
Other assets |
4,522 |
|
5,184 |
|
Non-current assets held for sale |
- |
|
145,888 |
|
|
|
|
||
Total assets |
746,651 |
|
855,852 |
|
|
|
|
||
LIABILITIES |
|
|
||
Current liabilities |
|
|
||
Accounts payable and accrued liabilities |
89,993 |
|
95,879 |
|
Notes payable |
44,446 |
|
- |
|
Income taxes payable |
521 |
|
957 |
|
Current portion of long-term debt |
46,695 |
|
38,491 |
|
Current portion of operating lease liabilities |
13,488 |
|
12,499 |
|
Current liabilities held for sale |
18,878 |
|
13,207 |
|
Total current liabilities |
214,021 |
|
161,033 |
|
|
|
|
||
Long-term debt |
268,093 |
|
269,993 |
|
Operating lease liabilities |
80,842 |
|
74,329 |
|
Deferred income taxes |
325 |
|
- |
|
Non-current liabilities held for sale |
- |
|
3,228 |
|
Total liabilities |
563,281 |
|
508,583 |
|
|
|
|
||
Series B-1 preferred stock |
14,385 |
|
28,062 |
|
|
|
|
||
SHAREHOLDERS' EQUITY |
|
|
||
Common shares |
462,630 |
|
440,348 |
|
Additional paid-in capital |
25,516 |
|
33,184 |
|
Accumulated deficit |
(320,524 |
) |
(155,688 |
) |
Accumulated other comprehensive income |
1,363 |
|
1,363 |
|
Total shareholders' equity |
168,985 |
|
319,207 |
|
|
|
|
||
Total liabilities and shareholders' equity |
746,651 |
|
855,852 |
|
|
|
|
||
SunOpta Inc. |
||||||||
Consolidated Statements of Cash Flows |
||||||||
For the quarters and three quarters ended September 30, 2023 and October 1, 2022 |
||||||||
(Unaudited) |
||||||||
(Expressed in thousands of |
||||||||
|
||||||||
|
Quarter ended |
Three quarters ended |
||||||
|
September 30, 2023 |
October 1, 2022 |
September 30, 2023 |
October 1, 2022 |
||||
|
$ |
$ |
$ |
$ |
||||
|
|
|
|
|
||||
CASH PROVIDED BY (USED IN) |
|
|
|
|
||||
Operating activities |
|
|
|
|
||||
Net loss |
(145,823 |
) |
(11,934 |
) |
(163,284 |
) |
(5,895 |
) |
Loss from discontinued operations |
(140,143 |
) |
(14,293 |
) |
(143,126 |
) |
(10,203 |
) |
Earnings (loss) from continuing operations |
(5,680 |
) |
2,359 |
|
(20,158 |
) |
4,308 |
|
Items not affecting cash: |
|
|
|
|
||||
Depreciation and amortization |
7,983 |
|
5,837 |
|
22,873 |
|
16,828 |
|
Amortization of debt issuance costs |
298 |
|
413 |
|
1,093 |
|
1,184 |
|
Deferred income taxes |
282 |
|
7,590 |
|
4,260 |
|
11,237 |
|
Stock-based compensation |
3,068 |
|
4,092 |
|
8,989 |
|
9,691 |
|
Other |
(96 |
) |
(74 |
) |
410 |
|
1,822 |
|
Changes in operating assets and liabilities, net of divestitures |
(31,708 |
) |
(10,878 |
) |
(25,852 |
) |
(21,651 |
) |
Net cash provided by (used in) operating activities of continuing operations |
(25,853 |
) |
9,339 |
|
(8,385 |
) |
23,419 |
|
Net cash provided by operating activities of discontinued operations |
16,521 |
|
10,634 |
|
18,798 |
|
9,643 |
|
Net cash provided by (used in) operating activities |
(9,332 |
) |
19,973 |
|
10,413 |
|
33,062 |
|
Investing activities |
|
|
|
|
||||
Additions to property, plant and equipment |
(4,716 |
) |
(37,371 |
) |
(37,272 |
) |
(98,742 |
) |
Proceeds from sale of property, plant and equipment |
- |
|
90 |
|
- |
|
4,182 |
|
Net cash used in investing activities of continuing operations |
(4,716 |
) |
(37,281 |
) |
(37,272 |
) |
(94,560 |
) |
Net cash provided by (used in) investing activities of discontinued operations |
(127 |
) |
15,373 |
|
(1,085 |
) |
7,750 |
|
Net cash used in investing activities |
(4,843 |
) |
(21,908 |
) |
(38,357 |
) |
(86,810 |
) |
Financing activities |
|
|
|
|
||||
Increase in borrowings under revolving credit facilities |
16,207 |
|
1,761 |
|
22,718 |
|
19,724 |
|
Borrowings of long-term debt |
507 |
|
33,094 |
|
19,840 |
|
74,197 |
|
Repayment of long-term debt |
(10,629 |
) |
(6,172 |
) |
(31,435 |
) |
(13,557 |
) |
Proceeds from notes payable |
42,507 |
|
- |
|
77,602 |
|
- |
|
Repayment of notes payable |
(17,788 |
) |
- |
|
(33,156 |
) |
- |
|
Proceeds from the exercise of stock options and employee share purchases |
255 |
|
612 |
|
831 |
|
1,203 |
|
Payment of withholding taxes on stock-based awards |
(114 |
) |
(631 |
) |
(9,121 |
) |
(1,602 |
) |
Payment of cash dividends on preferred stock |
(304 |
) |
(609 |
) |
(1,427 |
) |
(1,827 |
) |
Payment of share issuance costs |
(68 |
) |
- |
|
(191 |
) |
- |
|
Payment of debt issuance costs |
- |
|
(113 |
) |
- |
|
(672 |
) |
Net cash provided by financing activities of continuing operations |
30,573 |
|
27,942 |
|
45,661 |
|
77,466 |
|
Net cash used in financing activities of discontinued operations |
(13,835 |
) |
(26,101 |
) |
(14,852 |
) |
(23,486 |
) |
Net cash provided by financing activities |
16,738 |
|
1,841 |
|
30,809 |
|
53,980 |
|
Increase (decrease) in cash, cash equivalents and restricted cash in the period |
2,563 |
|
(94 |
) |
2,865 |
|
232 |
|
Cash and cash equivalent, beginning of the period |
981 |
|
553 |
|
679 |
|
227 |
|
Cash, cash equivalents and restricted cash, end of the period |
3,544 |
|
459 |
|
3,544 |
|
459 |
|
Non-GAAP Measures
In addition to reporting financial results in accordance with
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for, an analysis of the Company’s results as reported under
Adjusted Earnings/Loss
When assessing its financial performance, the Company uses an internal measure that excludes charges and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings/loss and adjusted earnings/loss per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with
The following is a tabular presentation of adjusted earnings/loss and adjusted earnings/loss per diluted share, including a reconciliation from net earnings/loss, which the Company believes to be the most directly comparable
Adjusted EBITDA
The Company defines adjusted EBITDA as operating income plus depreciation, amortization, stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings/loss. The following is a tabular presentation of adjusted EBITDA, including a reconciliation from net earnings/loss, which the Company believes to be the most directly comparable
|
Continuing |
Discontinued |
|
|||||||||
|
Operations |
Operations |
Consolidated |
|||||||||
|
|
Per Share |
|
Per Share |
|
Per Share |
||||||
For the quarter ended |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
September 30, 2023 |
|
|
|
|
|
|
||||||
Net loss |
(5,680 |
) |
|
(140,143 |
) |
|
(145,823 |
) |
|
|||
Dividends and accretion on preferred stock |
(426 |
) |
|
- |
|
|
(426 |
) |
|
|||
Loss attributable to common shareholders |
(6,106 |
) |
(0.05 |
) |
(140,143 |
) |
(1.21 |
) |
(146,249 |
) |
(1.26 |
) |
Adjusted for: |
|
|
|
|
|
|
||||||
Loss on divestiture of discontinued operations(a) |
- |
|
|
118,795 |
|
|
118,795 |
|
|
|||
Inventory reserves and impairment charges(b) |
- |
|
|
17,864 |
|
|
17,864 |
|
|
|||
Start-up costs(c) |
4,733 |
|
|
- |
|
|
4,733 |
|
|
|||
Business development costs(d) |
928 |
|
|
- |
|
|
928 |
|
|
|||
Severance costs(e) |
897 |
|
|
- |
|
|
897 |
|
|
|||
Other(f) |
- |
|
|
21 |
|
|
21 |
|
|
|||
Net income tax on adjusting items(g) |
- |
|
|
- |
|
|
- |
|
|
|||
Adjusted earnings (loss) |
452 |
|
0.00 |
|
(3,463 |
) |
(0.03 |
) |
(3,011 |
) |
(0.03 |
) |
|
|
|
|
|
|
|
||||||
October 1, 2022 |
|
|
|
|
|
|
||||||
Net earnings (loss) |
2,359 |
|
|
(14,293 |
) |
|
(11,934 |
) |
|
|||
Dividends and accretion on preferred stock |
(764 |
) |
|
- |
|
|
(764 |
) |
|
|||
Earnings (loss) attributable to common shareholders |
1,595 |
|
0.01 |
|
(14,293 |
) |
(0.13 |
) |
(12,698 |
) |
(0.12 |
) |
Adjusted for: |
|
|
|
|
|
|
||||||
Loss on divestiture of discontinued operations(a) |
- |
|
|
23,227 |
|
|
23,227 |
|
|
|||
Sale of frozen fruit processing facility(h) |
- |
|
|
(3,460 |
) |
|
(3,460 |
) |
|
|||
Start-up costs(c) |
608 |
|
|
- |
|
|
608 |
|
|
|||
Exit from fruit ingredient processing facility(i) |
206 |
|
|
- |
|
|
206 |
|
|
|||
Business development costs(d) |
75 |
|
|
- |
|
|
75 |
|
|
|||
Other(f) |
245 |
|
|
(18 |
) |
|
227 |
|
|
|||
Net income tax on adjusting items(g) |
(299 |
) |
|
(5,192 |
) |
|
(5,491 |
) |
|
|||
Adjusted earnings |
2,430 |
|
0.02 |
|
264 |
|
0.00 |
|
2,694 |
|
0.02 |
|
|
Continuing |
Discontinued |
|
|||
|
Operations |
Operations |
Consolidated |
|||
For the quarter ended |
$ |
$ |
$ |
|||
September 30, 2023 |
|
|
|
|||
Net loss |
(5,680 |
) |
(140,143 |
) |
(145,823 |
) |
Income tax benefit |
- |
|
(805 |
) |
(805 |
) |
Interest expense, net |
7,162 |
|
840 |
|
8,002 |
|
Depreciation and amortization |
7,983 |
|
2,966 |
|
10,949 |
|
Stock-based compensation |
3,068 |
|
- |
|
3,068 |
|
Adjusted for: |
|
|
|
|||
Loss on divestiture of discontinued operations(a) |
- |
|
118,795 |
|
118,795 |
|
Inventory reserves and impairment charges(b) |
- |
|
17,864 |
|
17,864 |
|
Start-up costs(c) |
4,733 |
|
- |
|
4,733 |
|
Business development costs(d) |
928 |
|
- |
|
928 |
|
Severance costs(e) |
897 |
|
- |
|
897 |
|
Other(f) |
- |
|
21 |
|
21 |
|
Adjusted EBITDA |
19,091 |
|
(462 |
) |
18,629 |
|
|
|
|
|
|||
October 1, 2022 |
|
|
|
|||
Net earnings (loss) |
2,359 |
|
(14,293 |
) |
(11,934 |
) |
Income tax expense (benefit) |
332 |
|
(5,296 |
) |
(4,964 |
) |
Interest expense, net |
3,901 |
|
441 |
|
4,342 |
|
Depreciation and amortization |
5,837 |
|
3,893 |
|
9,730 |
|
Stock-based compensation |
4,092 |
|
- |
|
4,092 |
|
Adjusted for: |
|
|
|
|||
Loss on divestiture of discontinued operations(a) |
- |
|
23,227 |
|
23,227 |
|
Sale of frozen fruit processing facility(h) |
- |
|
(3,460 |
) |
(3,460 |
) |
Start-up costs(c) |
608 |
|
- |
|
608 |
|
Exit from fruit ingredient processing facility(i) |
206 |
|
- |
|
206 |
|
Business development costs(d) |
75 |
|
- |
|
75 |
|
Other(f) |
245 |
|
(18 |
) |
227 |
|
Adjusted EBITDA |
17,655 |
|
4,494 |
|
22,149 |
|
(a) |
Reflects the estimated pre-tax loss on the divestiture of Frozen Fruit in the third quarter of 2023 and the pre-tax loss on the divestiture of Sunflower in the third quarter of 2022, which are recorded in loss from discontinued operations. |
(b) |
For the third quarter of 2023, reflects inventory reserves and impairment charges on equipment and operating lease right-of-use assets recognized in connection with the divestiture of Frozen Fruit, which are recorded in loss from discontinued operations. |
(c) |
For the third quarter of 2023, start-up costs included the ramp-up of production at our new plant-based beverage facility in |
(d) |
Represents third-party costs associated with business development activities, which are inclusive of costs related to the evaluation, execution, and integration of external acquisitions and divestitures, internal expansion projects, and other strategic initiatives. For the third quarters of 2023 and 2022, business development costs related to the divestiture of Frozen Fruit and are recorded in SG&A expenses. |
(e) |
For the third quarter of 2023, reflects employee severance costs accrued in connection with the consolidation of our continuing operations following the divestiture of Frozen Fruit, which are recorded in SG&A expenses. |
(f) |
Other includes reserves for legal settlements and gains and loss on the disposal of assets, which are recorded in other income/expense and loss from discontinued operations. |
(g) |
Reflects the tax effect of the adjustments to earnings calculated based on the statutory tax rates applicable in the tax jurisdiction of the underlying adjustment, net of deferred tax valuation allowances. |
(h) |
For the third quarter of 2022, reflects the gain on sale in August 2022 of a previously owned frozen fruit processing facility, net of exit costs, which is recorded in loss from discontinued operations. |
(i) |
For the third quarter of 2022, reflects exit costs related to a former fruit ingredient processing facility, which are recorded in other expense. |
|
Continuing |
Discontinued |
|
|||||||||
|
Operations |
Operations |
Consolidated |
|||||||||
|
|
Per Share |
|
Per Share |
|
Per Share |
||||||
For the three quarters ended |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
September 30, 2023 |
|
|
|
|
|
|
||||||
Net loss |
(20,158 |
) |
|
(143,126 |
) |
|
(163,284 |
) |
|
|||
Dividends and accretion on preferred stock |
(1,552 |
) |
|
- |
|
|
(1,552 |
) |
|
|||
Loss attributable to common shareholders |
(21,710 |
) |
(0.19 |
) |
(143,126 |
) |
(1.26 |
) |
(164,836 |
) |
(1.45 |
) |
Adjusted for: |
|
|
|
|
|
|
||||||
Loss on divestiture of discontinued operations(a) |
- |
|
|
118,795 |
|
|
118,795 |
|
|
|||
Inventory reserves and impairment charges(b) |
- |
|
|
17,864 |
|
|
17,864 |
|
|
|||
Start-up costs(c) |
17,855 |
|
|
- |
|
|
17,855 |
|
|
|||
Product recall costs, net of insurance recoveries(d) |
- |
|
|
2,500 |
|
|
2,500 |
|
|
|||
Business development costs(e) |
2,390 |
|
|
- |
|
|
2,390 |
|
|
|||
Severance costs(f) |
897 |
|
|
- |
|
|
897 |
|
|
|||
Other(g) |
(20 |
) |
|
519 |
|
|
499 |
|
|
|||
Net income tax on adjusting items(h) |
- |
|
|
- |
|
|
- |
|
|
|||
Change in valuation allowance for deferred tax |
|
|
|
|
|
|
||||||
assets(i) |
3,978 |
|
|
- |
|
|
3,978 |
|
|
|||
Adjusted earnings (loss) |
3,390 |
|
0.03 |
|
(3,448 |
) |
(0.03 |
) |
(58 |
) |
(0.00 |
) |
|
|
|
|
|
|
|
||||||
October 1, 2022 |
|
|
|
|
|
|
||||||
Net earnings (loss) |
4,308 |
|
|
(10,203 |
) |
|
(5,895 |
) |
|
|||
Dividends and accretion on preferred stock |
(2,279 |
) |
|
- |
|
|
(2,279 |
) |
|
|||
Earnings attributable to common shareholders |
2,029 |
|
0.02 |
|
(10,203 |
) |
(0.09 |
) |
(8,174 |
) |
(0.08 |
) |
Adjusted for: |
|
|
|
|
|
|
||||||
Loss on divestiture of discontinued operations(a) |
- |
|
|
31,468 |
|
|
31,468 |
|
|
|||
Sale of frozen fruit processing facility(j) |
- |
|
|
(2,544 |
) |
|
(2,544 |
) |
|
|||
Start-up costs(c) |
1,329 |
|
|
- |
|
|
1,329 |
|
|
|||
Business development costs(e) |
874 |
|
|
- |
|
|
874 |
|
|
|||
Exit from fruit ingredient processing facility(k) |
577 |
|
|
- |
|
|
577 |
|
|
|||
Other(g) |
831 |
|
|
(64 |
) |
|
767 |
|
|
|||
Net income tax on adjusting items(h) |
(949 |
) |
|
(16,414 |
) |
|
(17,363 |
) |
|
|||
Adjusted earnings |
4,691 |
|
0.04 |
|
2,243 |
|
0.02 |
|
6,934 |
|
0.06 |
|
|
Continuing |
Discontinued |
|
|||
|
Operations |
Operations |
Consolidated |
|||
For the three quarters ended |
$ |
$ |
$ |
|||
September 30, 2023 |
|
|
|
|||
Net loss |
(20,158 |
) |
(143,126 |
) |
(163,284 |
) |
Income tax expense (benefit) |
3,978 |
|
(636 |
) |
3,342 |
|
Interest expense, net |
19,391 |
|
1,392 |
|
20,783 |
|
Depreciation and amortization |
22,873 |
|
8,861 |
|
31,734 |
|
Stock-based compensation |
8,989 |
|
- |
|
8,989 |
|
Adjusted for: |
|
|
|
|||
Loss on divestiture of discontinued operations(a) |
- |
|
118,795 |
|
118,795 |
|
Inventory reserves and impairment charges(b) |
- |
|
17,864 |
|
17,864 |
|
Start-up costs(c) |
17,855 |
|
- |
|
17,855 |
|
Product recall costs, net of insurance recoveries(d) |
- |
|
2,500 |
|
2,500 |
|
Business development costs(e) |
2,390 |
|
- |
|
2,390 |
|
Severance costs(f) |
897 |
|
- |
|
897 |
|
Other(g) |
(20 |
) |
519 |
|
499 |
|
Adjusted EBITDA |
56,195 |
|
6,169 |
|
62,364 |
|
|
|
|
|
|||
October 1, 2022 |
|
|
|
|||
Net earnings (loss) |
4,308 |
|
(10,203 |
) |
(5,895 |
) |
Income tax expense (benefit) |
1,360 |
|
(15,978 |
) |
(14,618 |
) |
Interest expense, net |
8,844 |
|
1,160 |
|
10,004 |
|
Depreciation and amortization |
16,828 |
|
11,687 |
|
28,515 |
|
Stock-based compensation |
9,691 |
|
- |
|
9,691 |
|
Adjusted for: |
|
|
|
|||
Loss on divestiture of discontinued operations(a) |
- |
|
31,468 |
|
31,468 |
|
Sale of frozen fruit processing facility(j) |
- |
|
(2,544 |
) |
(2,544 |
) |
Start-up costs(c) |
1,329 |
|
- |
|
1,329 |
|
Business development costs(e) |
874 |
|
- |
|
874 |
|
Exit from fruit ingredient processing facility(k) |
577 |
|
- |
|
577 |
|
Other(g) |
831 |
|
(64 |
) |
767 |
|
Adjusted EBITDA |
44,642 |
|
15,526 |
|
60,168 |
|
(a) |
For the first three quarters of 2023, reflects the estimated pre-tax loss on the divestiture of Frozen Fruit which is recorded in loss from discontinued operations. For the first three quarters of 2022, reflects the pre-tax loss on the divestiture of Sunflower of |
(b) |
For the first three quarters of 2023, reflects inventory reserves and impairment charges on equipment and operating lease right-of-use assets recognized in connection with the divestiture of Frozen Fruit, which are recorded in loss from discontinued operations. |
(c) |
For the first three quarters of 2023, start-up costs included the ramp-up of production at our new plant-based beverage facility in |
(d) |
Reflects the self-insured retention amount under our insurance policies related to the recall of specific frozen fruit products initiated in the second quarter of 2023, which is recorded in loss from discontinued operations. |
(e) |
Represents third-party costs associated with business development activities, which are inclusive of costs related to the evaluation, execution, and integration of external acquisitions and divestitures, internal expansion projects, and other strategic initiatives. For the first three quarters of 2023, business development costs related to the divestiture of Frozen Fruit, and, for the first three quarters of 2022, these costs related to the divestitures of Frozen Fruit and Sunflower, together with our inaugural Investor Day held in June 2022. These costs were recorded in SG&A expenses. |
(f) |
For the first three quarters of 2023, reflects employee severance costs accrued in connection with the consolidation of our continuing operations following the divestiture of Frozen Fruit, which are recorded in SG&A expenses. |
(g) |
Other includes reserves for legal settlements and gains and loss on the disposal of assets, which are recorded in other income/expense and loss from discontinued operations. |
(h) |
Reflects the tax effect of the preceding adjustments to earnings calculated based on the statutory tax rates applicable in the tax jurisdiction of the underlying adjustment, net of deferred tax valuation allowances. In addition, for the first three quarters of 2022, reflects |
(i) |
For the first three quarters, reflects an increase to the valuation allowance for |
(j) |
For the first three quarters of 2022, reflects the gain on sale in August 2022 of a previously owned frozen fruit processing facility, net of exit costs, which is recorded in loss from discontinued operations. |
(k) |
For the first three quarters of 2022, reflects exit costs related to a former fruit ingredient processing facility, which are recorded in other expense. |
Quarterly Adjusted EBITDA from Continuing Operations
The following table presents quarterly adjusted EBITDA from continuing operations.
|
Fiscal 2023 |
|||||||
|
|
|
Three quarters |
|||||
|
Quarter ended |
ended |
||||||
|
April 1, 2023 |
July 1, 2023 |
September 30, 2023 |
September 30, 2023 |
||||
|
$ |
$ |
$ |
$ |
||||
Net loss |
(1,166 |
) |
(13,312 |
) |
(5,680 |
) |
(20,158 |
) |
Income tax expense (benefit) |
(3,965 |
) |
7,943 |
|
- |
|
3,978 |
|
Interest expense, net |
5,664 |
|
6,565 |
|
7,162 |
|
19,391 |
|
Depreciation and amortization |
7,050 |
|
7,840 |
|
7,983 |
|
22,873 |
|
Stock-based compensation |
3,892 |
|
2,029 |
|
3,068 |
|
8,989 |
|
Adjusted for: |
|
|
|
|
||||
Start-up costs |
6,425 |
|
6,697 |
|
4,733 |
|
17,855 |
|
Business development costs |
731 |
|
731 |
|
928 |
|
2,390 |
|
Severance costs |
- |
|
- |
|
897 |
|
897 |
|
Other |
42 |
|
(62 |
) |
- |
|
(20 |
) |
Adjusted EBITDA |
18,673 |
|
18,431 |
|
19,091 |
|
56,195 |
|
|
Fiscal 2022 |
||||||
|
Quarter ended |
Year ended |
|||||
|
April 2, 2022 |
July 2, 2022 |
October 1, 2022 |
December 31, 2022 |
December 31, 2022 |
||
|
$ |
$ |
$ |
$ |
$ |
||
Net earnings |
1,055 |
894 |
2,359 |
6,429 |
|
10,737 |
|
Income tax expense (benefit) |
212 |
816 |
332 |
(7,320 |
) |
(5,960 |
) |
Interest expense, net |
2,153 |
2,790 |
3,901 |
4,312 |
|
13,156 |
|
Depreciation and amortization |
5,350 |
5,641 |
5,837 |
6,219 |
|
23,047 |
|
Stock-based compensation |
1,629 |
3,970 |
4,092 |
4,139 |
|
13,830 |
|
Adjusted for: |
|
|
|
|
|
||
Start-up costs |
440 |
281 |
608 |
4,699 |
|
6,028 |
|
Business development costs |
183 |
616 |
75 |
296 |
|
1,170 |
|
Exit from fruit ingredient processing facility |
- |
371 |
206 |
- |
|
577 |
|
Other |
304 |
282 |
245 |
243 |
|
1,074 |
|
Adjusted EBITDA |
11,326 |
15,661 |
17,655 |
19,017 |
|
63,659 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20231108998682/en/
Investor Relations:
Reed Anderson
ICR
646-277-1260
reed.anderson@icrinc.com
Media Relations:
Konnect Agency
213-988-8344
sunopta@konnectagency.com
Source: SunOpta Inc.
FAQ
What are SunOpta's Q3 2023 financial results?
What is the impact of the divestiture of frozen fruit operations?
What is SunOpta's outlook for Q4 2023?
What is SunOpta's 2024 outlook?
